Clinical Utility of Total Cholesterol to HDL Ratio
Introduction to the Ratio
- The total cholesterol/HDL ratio is a valuable risk assessment tool, but should not be used as a treatment target, instead focus on absolute LDL cholesterol goals based on cardiovascular risk category, as recommended by the European guidelines 1
- The total cholesterol/HDL cholesterol ratio combines atherogenic lipoproteins with protective HDL cholesterol into a single risk marker, making it clinically useful for cardiovascular risk stratification 1
Risk Assessment and Interpretation
- The European guidelines explicitly state that no specific treatment goals are defined for HDL cholesterol, and the ratio should be used as a marker of increased risk rather than as a therapeutic target 2, 3, 1
- A total cholesterol/HDL ratio is specifically recommended when using the SCORE cardiovascular risk model, particularly in patients with rheumatoid arthritis 4
- HDL cholesterol <1.0 mmol/L (40 mg/dL) in men and <1.2 mmol/L (46 mg/dL) in women serve as markers of increased cardiovascular risk 2, 3
Treatment Approach
- Treatment should focus on absolute LDL cholesterol goals based on cardiovascular risk category, rather than targeting a specific ratio 2, 3, 5, 1
- For primary prevention in asymptomatic individuals, the general goal is total cholesterol <5 mmol/L (190 mg/dL) and LDL cholesterol <3 mmol/L (115 mg/dL) 2, 3
- For high-risk individuals (10-year cardiovascular death risk ≥5%), the goal is total cholesterol <4.5 mmol/L (175 mg/dL) and LDL cholesterol <2.5 mmol/L (100 mg/dL) 2, 3
- For secondary prevention in established CVD or diabetes, the goal is total cholesterol <4.5 mmol/L (175 mg/dL) and LDL cholesterol <2.5 mmol/L (100 mg/dL), with more recent guidelines suggesting even lower targets: LDL <1.8 mmol/L (70 mg/dL) or at least a 50% reduction in LDL for very high-risk patients 2, 3, 5
Calculation and Assessment
- The Friedewald formula for calculating LDL cholesterol is invalid when triglycerides exceed 4.5 mmol/L (400 mg/dL), in such cases, use direct LDL measurement or newer calculation methods like the Sampson-NIH2 equation (valid up to triglycerides of 9 mmol/L) 5
- Measure total cholesterol first in asymptomatic individuals for initial screening, and if total cholesterol ≥6.5 mmol/L (250 mg/dL), obtain complete fasting lipid profile including HDL and triglycerides 2, 3
Lipid Profile Ratios and Clinical Interpretation
Introduction to Lipid Ratios
- The TC/HDL-C ratio provides additional risk stratification information beyond individual lipid components, according to the European Heart Journal 6, 7
- The TC/HDL-C ratio is especially valuable in women and patients with diabetes or metabolic syndrome, where total cholesterol alone may be misleading, as noted by the European Heart Journal 6, 7
Total Cholesterol/HDL-C Ratio
- The TC/HDL-C ratio captures cardiovascular risk more accurately than LDL-C/HDL-C ratio in patients with elevated triglycerides, as it accounts for atherogenic remnant particles not reflected in calculated LDL-C 6, 7
Clinical Application of Lipid Ratios
- The European Society of Cardiology recommends using the Friedewald formula for LDL-C calculation, which is LDL-C = TC - HDL-C - TG/2.2 (mmol/L) or TG/5 (mg/dL), as cited in the European Heart Journal 6, 7
- The American Heart Association suggests that the TC/HDL-C ratio is a useful marker for cardiovascular risk assessment, particularly in patients with rheumatoid arthritis or other inflammatory conditions 6, 7